Drug Testing

With increased public opinion on marijuana legalization, the increased use of marijuana and other illicit substances; the challenges and effects of the COVID-19 pandemic, and managing remote workforces, employers are being challenged with creating safe, healthy, and effective work environments amid an ongoing recruitment and retention crisis. Some employers may look to their substance abuse policy to see if they can make any changes to potentially create a competitive advantage. Employers should be cautioned that the U.S.

With so many employers struggling to hire and keep talented workers, employers might be looking for shortcuts to hire faster. Some employers have lowered job requirements, such as college degrees, and others have walked a risky line by eliminating or postponing background screening and using conditional offers of employment.

Happy New Year! 

The New York Department of Labor released additional guidance in response to the wave of questions related to the adult-use of cannabis and the Marijuana Regulation and Taxation Act (“MRTA”). This guidance is intended to address some of the most common situations or questions in the workplace. Please note that this guidance does not address the medical use of cannabis.

Discrimination Prohibited

A year of unprecedented challenges resulting from the global pandemic has dramatically shifted how we all attract, hire, screen, and onboard new talent.

Employers across the globe have had to quickly adapt to a new world of hybrid or work-from-home environments, converting to virtual hiring processes in order to complete daily tasks such as interviews and onboarding.

As of June 18, 2021, as this could change at any time, 37 states allow the medical use of marijuana, and 18 states permit the adult use of marijuana.[1] Many employers, and undoubtedly multi-state employers, are struggling with new rules that impact their operations. What do these new rules mean for workplace drug testing programs?  Should employers continue testing for marijuana? – can they?

A year after the pandemic, the 25th Health Care Compliance Association (HCCA) Compliance Institute took place virtually this past week. As the healthcare industry adapts to the new normal, HCCA’s conference provides an opportunity for compliance professionals to learn about the latest developments and priorities from regulators.

A survey from the Current Consulting Group (CCG) reports that since the start of the pandemic in 2020, 21% of employers have reported a drop of 61% or more in the number of drug tests that they perform on employees. There are combined factors in play, including high unemployment rates, but the majority of the decline resulted from concern about workplace drug testing safety and COVID-19 precautions.

Workplace drug testing has been around for more than forty years in the U.S.  At the start, drug testing was all about compliance with federal rules and has since evolved with state-specific laws and case laws that employers also need to follow. The primary goal of these rules is to maintain safety in our workplaces.

As I compile PreCheck’s annual list of most popular blog posts this year, I am reminded of everything that we faced in 2020. In a year that transformed the world via the ongoing COVID-19 pandemic, PreCheck and our parent company Cisive focused on providing resources for employers and clients to overcome the challenges presented by the coronavirus.